T2D was earlier established to activate PPARα, a transcription factor that up‐regulates the uptake and metabolism of myocardial free fatty acids, leading to excessive accumulation of FA in cardiomyocytes.34 The treatment with MH in this study improved these unfavourable changes, including elevated CPT1 and decreased PPARα. Here, PPARA is linked to type 2 diabetes mellitus.